Novo Nordisk to Cut Wegovy Prices in India by Up to 37%

The Danish pharmaceutical firm aims to make its weight-loss drug more accessible in the Indian market through substantial price reductions.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Wegovy: A prescription weight-loss medication containing semaglutide, developed by Novo Nordisk.